Use of Pharmacokinetic and Pharmacodynamic Analyses to Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Serious Gram-Positive Infections
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01184-17
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2017
Authors
Publisher
American Society for Microbiology